Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Three Rivers Pharmaceuticals, Llc Protects Its Intellectual Property
June 26th, 2007
Three Rivers Pharmaceuticals, LLC, a leading specialty drug manufacturer today announced that it has sued Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited for infringement of Three Rivers' United States Patent No. 6,720,000. The '000 patent is directed to a new and important process for producing ribavirin pellets using wet granulation. Ribavirin is a synthetic nucleoside analog with broad spectrum antiviral properties used to treat patients with Hepatitis C and other viral infections. The lawsuit against Zydus and Cadila, now pending in the United States District Court for the Eastern District of Virginia, seeks to enjoin those defendants from making,...
Source: Drug Law Weekly (2007-06-26)
|
